Grace Therapeutics, Inc. (GRCE)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $36.81M
Last updated: Nov 17, 2026 at 4:15 PM ET
Grace Therapeutics, Inc. (GRCE) Stock Chart
Grace Therapeutics (GRCE) has a latest price of $1.72 on Nov 17, 2026, 66.8% below its 52-week high of $5.18. Its price fell 43.8% over the past 12 months.
Price Chart
From Oct 2024 to Oct 2026, its highest month-end close was $4.63 in Mar 2026 and its lowest $1.94 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart GRCE with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for GRCE.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 21.8%, and over 6 months it fell 20.0%.
| Period | Change |
|---|---|
| 1 month | -8.5% |
| 3 months | -21.8% |
| 6 months | -20.0% |
| 12 months | -43.8% |
| 12 months, with dividends | -43.8% |
Price by Year
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $1.94 | -43.9% |
| 2025 | $3.46 | -7.5% |
Trading Range
The price is 13.8% below its 50-day average of $1.99 and 36.4% below its 200-day average of $2.71.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $1.72 | |
| 52-week high | $5.18 | -66.8% |
| 52-week low | $1.67 | +3.0% |
| 50-day average | $1.99 | -13.8% |
| 200-day average | $2.71 | -36.4% |
Price Risk
Over 3 years, its largest fall from a peak was 66.5%.
| Measure | Value |
|---|---|
| 1-year beta | 0.95 |
| Largest fall, 1 year | -66.5% |
| Largest fall, 3 years | -66.5% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About GRCE
What is GRCE's 1-year price change?
Grace Therapeutics's price fell 43.8% over the past 12 months. With dividends included, the 12-month total return was -43.8%.
What is GRCE's 52-week high and low?
Grace Therapeutics's 52-week high is $5.18 and its 52-week low is $1.67. Its latest price of $1.72 on Nov 17, 2026 is 66.8% below the high.
What is GRCE's beta?
Grace Therapeutics's 1-year beta against the S&P 500 is 0.95, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 66.5%.
Is the GRCE chart free?
Yes. Advanced Charting for GRCE is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
GRCE pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors